Table 2.
Usual Care Group | NaCl Group | Group | P Value | |
---|---|---|---|---|
Systolic blood pressure, mmHg | ||||
Year 0 | 153.7 (13.3) | 156.1 (15.7) | 155.3 (13.7) | 0.75* |
Year 10 | 134.1 (8.9) | 133.0 (7.6) | 135.6 (7.1) | 0.25* |
P value† | <0.01 | <0.01 | <0.01 | |
Urine Na+ excretion, mmol/8 h | ||||
Year 0 | 78.4 (5.8) | 77.3 (6.0) | 75.9 (6.1) | 0.82* |
Year 10 | 75.8 (6.0) | 87.6 (5.9) | 84.3 (6.2) | <0.01* |
P value† | 0.25 | <0.01 | <0.01 | |
Urine K+ excretion, mmol/8 h | ||||
Year 0 | 36.8 (5.1) | 34.6 (5.3) | 35.5 (5.0) | 0.85* |
Year 10 | 35.3 (5.2) | 36.0 (5.2) | 37.8 (5.1) | 0.23* |
P value† | 0.63 | 0.19 | 0.039 |
Values are means (SD); n = 40 participants/group. Patients with chronic kidney disease stage 2 were divided into the following three groups: usual care or treatment with oral NaCl or NaHCO3 (). P values at the end of the rows compare values in that row.
Kruskal-Wallis test for comparing three groups. All other P values were from one-way ANOVA.
P values below year 0 and year 10 values compare values for those years.